FDA Inspection 1167127 — Harborview Medical Center

Harborview Medical Center — FEI 3000281640

The FDA completed an inspection of Harborview Medical Center on March 28, 2022 in Seattle, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
March 28, 2022
Fiscal Year
2022
Product Type
Biologics
Project Area
Vaccines and Allergenic Products
Location
Seattle, WA (United States)